Shanghai Utopharm Co.,Ltd

UTOpharm（Shanghai）Co., Ltd., founded in 2004 in Shanghai, specialized in development, manufacture and marketing of pharmaceutical intermediates and APIs.

UTOpharm has its own research center and production base. The research center is located in Shanghai, owning a strong innovative research and development team with rich experience in organic synthesis area and specializing in research & development of new products and optimization of new production process. The production base is located in Zhejiang and Jiangsu province. UTOpharm is equipped with a variety of equipments(1-3000L), including two low–temperature reaction kettles (500L, -70℃) and one hydrogen reactor (500L, 11mPa), which can satisfy a variety of chemical reaction from small-scale tests, pilot experiments and scale up production. Meanwhile, our company is equipped with many analytical devices, such as HPLC and GC.

UTOpharm lays great emphasis on the customer's demands and regards customer satisfaction as its priority all the time. Furthermore, UTOpharm is endeavored in establishing long-term, various, and mutual-benefit cooperation with companies worldwide.

Basic Activities on:

Pre-clinical research of generic drugs;                   Contract research;   

Contract synthesis;                                                 Contract manufacturing;

Registration of drugs;                                            Optimization of synthesis process

Patents situation:

Ivabradine HCl:

CN101284813B, CN101353325B

Ulipristal Acetate:

EP2774933, WO2013063859, CA2851399, AU2012331996, CN102516345B, CN102675395B,  US2014296510 (A1) , CN 102675395, JP2014528459 (A) , CN103755765A, MX2014005245 (A),

Apremilast:

CN201410335852.6, CN201410420960.3，CN201510101009.6